CLEERLY AI guided CT Scan of the Heart

For over ten years, Cleerly has been leading the way in heart health research, conducting some of the largest clinical trials to uncover critical insights that go beyond just symptoms to reveal hidden risks of heart attacks. Unlike traditional heart disease assessments, Cleerly’s approach offers a thorough analysis of plaque buildup in the heart’s arteries, using advanced AI to interpret cardiac CT scans. This cutting-edge method helps doctors identify dangerous plaques that traditional techniques might miss. Cleerly’s non-invasive, AI-powered technology, approved by the FDA, allows for personalized treatment plans based on the actual state of a patient’s heart disease, not just traditional risk factors.